MEMOTEXT Collaborating with Johns Hopkins University To Evaluate Technology-Driven Adherenc... (plan. With the Internet and mobile phone...)

MEMOTEXT Collaborating with Johns Hopkins University To Evaluate Technology-Driven Adherence Programs

Date:1/13/2009

plan. With the Internet and mobile phones so prevalent in patients' lives, they offer new ways to customize a patient adherence regimen. The results of this study should demonstrate MEMOTEXT program's usefulness for glaucoma, as well as the many other chronic diseases where adherence is important.

"Adherence to glaucoma therapy is one of the largest barriers we face in achieving therapeutic success," said glaucoma specialist Donald Budenz, M.D., M.P.H., of the Bascom Palmer Eye Institute in Miami. "We have numerous effective medications to treat this disease, but if patients don't use them, they're not effective. Providing real-time reminders to improve adherence to therapy will be a major step forward in the treatment of chronic diseases such as glaucoma."

The Be Well Fund is designed to stimulate not-for-profit research and development across a broad range of health disciplines that have the potential to significantly improve health and wellness outcomes by seeding innovative avenues of research and exploring the potential for disruptive improvements to health management enabled by re-use and sharing of data among people, families, caregivers, doctors and facilities.

"The Be Well Fund winners share our vision of using the Internet to empower people to fully engage in managing their health and improving health outcomes," said David Cerino, general manager of the Health Solutions Group at Microsoft Corp. "We're excited to help these organizations turn their ideas into reality and to expand the capabilities and services available through HealthVault."

Microsoft received nearly 200 proposals from leading academic and health research organizations across the United States, making it one of the most successful Microsoft Research RFPs in the company's history. Based on the strong interest, Microsoft increased award funding from $3 million to $4.5 million to help bring these proposals to market.

    About "The Impact o
'/>"/>
SOURCE  MEMOTEXT Personalized Adherence Solutions
Copyright©2009 PR Newswire.
All rights reserved 
2

GOOD

Page: 1 2 3 4 
Related medicine news :

1. Pennsylvania Patient Safety Authority Launches New Website and Design With New Tagline Analyzing, Educating and Collaborating for Patient Safety
2. Four Abstracts by Biopure and Collaborating Scientists Accepted for Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
3. Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
4. Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of Omrix
5. YMCA of the USA Expands Healthy Communities Initiatives With $6.8 Million Grant from the Robert Wood Johnson Foundation
6. Johnson Matthey Medical Announces Expansion 
7. Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions
8. Robert Wood Johnson Foundation Awards Grants to Nine Communities In Launch of $44 Million National Program to Reverse Childhood Obesity
9. Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day
10. Johns Hopkins and Makerere University to collaborate on  African health education initiative
11. Johnson & Johnson Begins Tender Offer to Acquire Omrix

Post Your Comments:

(Date:12/16/2009)... will continue to offer free nationwide confidential legal consultations for ... effects such as: Birth Defects, Attempted Suicide, Suicide and Addiction ... free at 1-800-856-6405 or go to the firm’s website at ... form. , ... (PRWEB) December 16, ...

(Date:12/15/2009)... Austrian researchers have successfully developed a new electrophoretic ... in the blood. The technique, using SARCOSYL-PAGE, ... not alter the performance characteristics of SDS-PAGE for ... funded by a grant from the World Anti-Doping ... Drug Testing and Analysis published by ...

(Date:12/15/2009)... Board: SNKTY), a Life Sciences company engaged in the research, development and commercialization of technologies ... resolutions that the Company had proposed at the Annual General Meeting of Shareholders held on ... Votes ... Non-, Matter ... For Against ...

(Date:12/15/2009)... of America and the Saint Thomas, Lupus Trust ... son of the legendary John Lennon, and James Scott ... raise funds for research on the disease lupus. From ... proceeds from downloading "LUCY" at iTunes will be donated ... Saint Thomas, Lupus Trust in Great Britain. ,, Both ...

(Date:12/15/2009)... associated with lower dementia risk, research finds , , TUESDAY, ... leptin, a hormone that regulates appetite, may guard against ... or 15 years this may be one of many ... Alzheimer,s disease," said senior study author Dr. Sudha Seshadri, ... of Medicine. "Or it may be one of many ...

Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2 Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3 Health News:Researchers discover novel method for detecting MIRCERA 2 Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2 Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3 Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2 Health News:Fat Hormone May Protect Against Alzheimer's 2 Health News:Fat Hormone May Protect Against Alzheimer's 3

[0] Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil [1] Researchers discover novel method for detecting MIRCERA [1] Senetek PLC Announces 2009 Annual General Meeting Voting Results [0] Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research [0] Fat Hormone May Protect Against Alzheimer's

... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), a leading ... States, today announced that,it will host a conference call ... management to review the company,s third quarter results. ... conference call will be held on Wednesday, October,31, 2007 ...

... Injustice, Will Challenge,Corporate-Backed Proponents of "Health Courts", ... Nance, co-author of the groundbreaking new report on ... featured speakers at a,patient safety forum in Cheyenne, ... the merits and weaknesses of the health courts ...

... http://www.medikeeper.com ), a leading provider of technology solutions ... Series A investment round,led by Hawaii-based venture capital ... by a team of entrepreneurs and medical,professionals with ... accessible online. Beginning with its flagship Personal Health ...

... New T-Shirt Design Marks 2007 Race in San Diego, ... Komen San,Diego Race for the Cure(R) will be held in ... than three weeks until the Race, participants still,have two final ... http://www.komensandiego.org until Monday, October 22 or visit,Roadrunner Sports at ...

... Massachusetts,is not a model for California health reform, according ... to buy private health coverage.,Coverage in Massachusetts is already ... not capped or regulated, have indicated rates,will increase again ... Massachusetts law, which provides an,overview of the cost and ...

... the drugs are used with certain painkillers, study finds ... called selective serotonin reuptake inhibitors (SSRIs), which include Celexa, ... gastrointestinal bleeding, and the threat is more than six ... medications at the same time as SSRIs, a new ...

Other Medicine News:Health News:NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call 2 Health News:'Health Courts' Critic to be Featured Speaker at Wyoming Patient Safety Panel 2 Health News:MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor 2 Health News:Susan G. Komen Race(R) for the Cure Set for November 4 in Balboa Park 2 Health News:Susan G. Komen Race(R) for the Cure Set for November 4 in Balboa Park 3 Health News:Massachusetts Mandatory Health Insurance Purchase Law is No Model for California 2 Health News:Massachusetts Mandatory Health Insurance Purchase Law is No Model for California 3 Health News:Massachusetts Mandatory Health Insurance Purchase Law is No Model for California 4 Health News:Antidepressants Boost GI Bleeding Risk 2

NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call 'Health Courts' Critic to be Featured Speaker at Wyoming Patient Safety Panel MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor Susan G. Komen Race(R) for the Cure Set for November 4 in Balboa Park Massachusetts Mandatory Health Insurance Purchase Law is No Model for California Antidepressants Boost GI Bleeding Risk

(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... http://www.reportlinker.com/p0168539/Boehringer-Ingelheim-GmbH-PharmaVitae-Profile.html ,, Introduction ... forecast performance for Boehringer Ingelheim in the ... strategy, portfolio and pipeline analysis and assessment ...

(Date:12/15/2009)... Dec. 15 Waters ... that SDMS Vision Publisher(TM) (v.7.1 SR4), an electronic ... Management System (SDMS), a secure electronic repository that ... to a centralized database and is used to ... certified compliant with the SAFE-BioPharma digital identity and ...

(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...

[0] Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile [0] Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard [0] Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

... sustained levels of drug reported after one treatmentLOUISVILLE, ... held biotechnology company developing medicines for the treatment ... it successfully completed its Phase I ASaP (Assessment ... with Neovascular Age-Related Macular Degeneration) clinical trial for ...

... Up To $55 Million in Near Term Payments ... today announced that the company has entered into ... European rights to develop and commercialize the investigational ... syndrome with constipation (IBS-C) and other gastrointestinal conditions. ...

Other Medicine Technology:Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II 2 Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II 3 Ironwood Announces Linaclotide European Licensing Agreement with Almirall 2 Ironwood Announces Linaclotide European Licensing Agreement with Almirall 3

Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II Ironwood Announces Linaclotide European Licensing Agreement with Almirall

The HearTwave system is the original stand-alone Microvolt T-Wave Alternans (MTWA) testing platform....

... trabeculum provides the highest magnification of ANY gonioscopy ... treating the trabecular meshwork. One 62° mirror ... angle while the central portion of the lens ... for signs of glaucoma and other central retinal ...

The Mid Field 30° lens has a bi-concave design to provide a wider field of view with a 30 degree offset image....

... AFX Lens is a direct ... in an air-filled eye. In ... a primary air-fluid exchange vitrectomy ... sutureless design make it well ...

Medicine Products:

HearTwave Microvolt T-Wave Alternans System G-1 trabeculum Direct Image Mid Field 30 Prism Direct Image AFX SSV®

MEMOTEXT Collaborating with Johns Hopkins University To Evaluate Technology-Driven Adherenc...(plan. With the Internet and mobile phone...),Health